Pfizer has been making waves in the pharmaceutical world. It recently outmaneuvered Novo Nordisk to secure a deal for Metsera. This win has given Pfizer's stock a boost. But the company's success isn't just about one deal. Pfizer's third-quarter earnings were impressive. They beat Wall Street's exp
Pfizer's decision to offload its remaining shares in BioNTech (BNTX) has raised eyebrows. This move hints at a lack of faith in BioNTech's COVID-19 vaccine and its stock potential. BioNTech, once a profit powerhouse, is now facing significant losses. Its shares, though not cheap, reflect a company s
BMW, a well-known car company, is thinking about adding range extenders to some of its electric vehicles. This idea comes as more and more people in China are showing interest in this technology. Range extenders are small engines that give electric cars a longer driving range. The company is consid
Pfizer recently shared its fourth-quarter 2024 earnings. Their reported sales for COVID-19 products skyrocketed beyond what experts had guessed. This achievement was made possible by the company’s ongoing efforts to reduce costs. Shares of Pfizer went up by 2% in early trading. This jump ca
Pfizer recently shared impressive Q3 results that overshot expectations, thanks to its Covid vaccine and antiviral pill, Paxlovid. The drug giant raised its earnings and revenue projections for the year. Despite the positive news, shares dropped by over 2%. Pfizer's CEO, Albert Bourla, is under pres
Pfizer's third-quarter earnings just came in, and guess what? They're way better than expected! The company's making a lot more money, thanks to a big demand for their COVID-19 treatments. Their best-selling drug, Paxlovid, brought in a whopping $2. 7 billion in the third quarter alone. This is a ma
Pfizer, a major player in the pharmaceutical industry, has recently shared more details about its weight loss drug pipeline. This comes as part of their efforts to compete in the growing market for weight loss medications, currently dominated by Novo Nordisk and Eli Lilly. These companies have found
Pfizer, one of the world's largest pharmaceutical companies, surprised many analysts with its third-quarter earnings. The company reported earnings of $1. 06 per share, well above the expected $0. 61. Sales also exceeded expectations, coming in at $17. 7 billion compared to the projected $14. 92 bil
Pfizer, a pharmaceutical giant, has been in the spotlight lately. Investors have been discussing the company's future under CEO Dr. Albert Bourla. Recently, an activist investor named Starboard Value shared some thoughts on Pfizer. They pointed out issues but also emphasized the company's potential.
Pfizer Inc. has shared some exciting news! Their new medicine, HYMPAVZI (marstacimab-hncq), just got the green light from the U. S. Food and Drug Administration. This medication is designed to help people with hemophilia A and B prevent or reduce bleeding episodes. Hemophilia is a rare condition th
